Dan has over a decade of laboratory experience working across materials science, environmental analysis, and contract research.

As Analytical Development Team Leader he manages a team focused on method development, validation, and continuous improvement.

Industry experience

Daniel has eight years experience of GC-MS starting with environmental analysis of semi-volatile pollutants, his next role was performing high-resolution mass spec analysis of dioxins. He joined Element Manchester in 2018 working initially in the gas chromatography team before focusing on research and development and becoming team leader.


Career highlights 

  • Implemented a new procedure of the validation of methods to industry guidelines and standards including ICH Q2
  • Developed an approach to qualification of methods for untargeted analysis
  • Developed and validated methods for HPCH analysis in reduced risk products





  • Affiliate Member of the Royal Society of Chemistry 


Sector Expertise 

  • Pharmaceuticals
  • Consumer healthcare
  • Medical devices

Connect with Daniel on LinkedIn

Rapid Response Team

Rapid Response Services

Element's Rapid Response team cater to your time-sensitive analytical needs with bespoke investigatory analysis of pharmaceutical products.

Available to our European, Middle East and Asian clients, our Rapid Response solutions cover a wide range of analytical needs from impurity characterization, to investigational problem-solving, and comprehensive analytical method development & validation.

Our capabilities cover all aspects of pharmaceutical and consumer healthcare product testing, boasting cutting-edge instrumentation and expertise to help customers resolve complex issues efficiently.

Element Manchester is a globally respected Life Science laboratory based in Manchester, UK, specializing in complex trace analytical chemistry.

Extractables & Leachables Studies

Element has one of the largest and most experienced extractables and leachables (E&L) practices in the world.

Backed by regulatory expertise, extensive experience, and a vast extractables database, our comprehensive E&L solutions ensure the safety of materials used across the healthcare sector.

We deliver tailored studies for pharmaceutical, biologic, medical device, reduced risk, combination products and more, in accordance with regulatory expectations.


Related Pages

Pharmaceutical Testing Extractables and Leachables

Extractables and Leachables Studies

Element's extractables and leachables studies offer tailored solutions that ensure patient safety and compliance with industry standards.

Read More

Medical Device Testing

As a comprehensive testing partner, you’ll enjoy the benefit of a single supplier source for all of your testing needs, from mechanical testing and environmental simulation to EMC and wireless device testing.

Read More
pharmaceutical testing

Pharmaceutical Testing

Element’s pharmaceutical laboratories provide specialist pharmaceutical testing services, including chemical, physical, microbial, and stability testing on a vast array of products, from raw materials to finished products.

Read More
IS0 18562-2

ISO 18562 Testing: Biocompatibility Analysis

Element provides ISO 18562 biocompatibility analysis for respiratory and ventilation devices to support global device approval.

USP 665 Testing

USP 665, 1665 and BPOG Services

Ensure compliance for single-use systems (SUS). Our testing services provide high-quality results, safeguarding patient safety, fulfilling your regulatory requirements, and expediting time to market.

Pharmaceutical raw materials testing

Excipient Raw Materials and Container Testing

Find out how we make certain that quality and safety of your excipient raw materials and containers are maintained.

Connect with Element Life Sciences.

Chemistry, Manufacturing, and Controls (CMC) Consulting Services

We provide consulting services for Chemistry, Manufacturing, and Controls (CMC) product development in the pharmaceutical and biotechnological industries.

Connect with Element Life Sciences

ICH Stability Testing of Pharmaceuticals and Biologics

We'll help you develop comprehensive stability programs that meet ICH Q1A-F requirements for IND, ANDA, and NDA approvals of small and large molecule drugs. 

Read more

Our team of over 9,000 Engaged Experts in North America, Europe, The Middle East, Australia, Asia and Africa are ready to help you.